Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats

Anaerobe

Volumn 24, Issue , 2013, Pages 4-11

  Bejar, Wacim ^a   Hamden, Khaled ^b   Ben Salah, Riadh ^a   Chouayekh, Hichem ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b Faculté des Sciences de Sfax   (Tunisia)

Author keywords

Alloxan induced diabetes; Antidiabetic effects; Lactobacillus plantarum TN627; Liver and kidney functions; Pancreas; Probiotic

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL STRAIN; CHOLESTEROL BLOOD LEVEL; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LACTOBACILLUS PLANTARUM; LIVER FUNCTION; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; TISSUE SECTION; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ALLOXAN-INDUCED DIABETES; ANTIDIABETIC EFFECTS; LACTOBACILLUS PLANTARUM TN627; LIVER AND KIDNEY FUNCTIONS; PANCREAS; PROBIOTIC;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; LACTOBACILLUS PLANTARUM; MALE; PROBIOTICS; RATS; RATS, WISTAR;

EID: 84884139516     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.08.006     Document Type: Article

References (39)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Trucco M. Gene-environment interaction in type 1 diabetes mellitus. Endocrinol Nutr 2009, 56:56-59.
3. Todd J.A. Etiology of type 1 diabetes. Immunity 2010, 32:457-467.
4. Galli F., Piroddi M., Annetti C., Aisa C., Floridi E., Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol 2005, 149:240-260.
5. Hamden K., Carreau S., Boujbiha M.A., Lajmi S., Aloulou D., Kchaou D., et al. Hyperglycemia, stress oxidant, liver dysfunction and histological changes in diabetic male rat pancreas and liver: protective effect of 17β-estradiol. Steroids 2008, 73:495-501.
6. Stanton R.C. Oxidative stress and diabetic kidney disease. Curr Diab Rep 2011, 11:330-336.
7. McCall A.L. Insulin therapy and hypoglycemia. Endocrin Metab Clin 2012, 41:57-87.
8. Daly Use of insulin and weight gain: optimizing diabetes nutrition therapy. JAm Diet Assoc 2007, 107:1386-1393.
9. Charbonnel B., Penfornis A., Varroud-Vial M., Kusnik-Joinville O., Detournay B. Insulin therapy for diabetes mellitus: treatment regimens and associated costs. Diabetes Metab 2012, 38:156-163.
10. Yadav H., Jain S., Sinha P.R. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007, 23:62-68.
11. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocrinol Jpn 1997, 44:357-365.
12. Tabuchi M., Ozaki M., Tamura A., Yamada N., Ishida T., Hosoda M., et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003, 67:1421-1424.
13. Calcinaro F., Dionisi S., Marinaro M., Candeloro P., Bonato V., Marzotti S., et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005, 48:1565-1575.
14. Valladares R., Sankar D., Li N., Williams E., Lai K.K., Abdelgeliel A.S., et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 2010, 5:e10507.
15. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
16. Park Y.H., Kim J.G., Shin Y.W., Kim S.H., Whang K.Y. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. JMicrobiol Biotechnol 2007, 17:655-662.
17. Lye H.S., Kuan C.Y., Ewe J.A., Fung W.Y., Liong M.T. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, rennin and phytoestrogens. Int J Mol Sci 2009, 10:3755-3775.
18. Lu Y.C., Yin L.T., Chang W.T., Huang J.S. Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats. JBiosci Bioeng 2010, 110:709-715.
19. Bejar W., Farhat-Khmakhem A., Smaoui S., Makni M., Ben Farhat M., Abdelmalek B., et al. Selection of Lactobacillus plantarum TN627 as a new probiotic candidate based on invitro functional properties. Biotechnol Bioproc Eng 2011, 16:1115-1123.
20. Hamden K., Jaouadi B., Carreau S., Aouidet A., El-Fazaa S., Gharbi N., et al. Potential protective effect on key steroidogenesis and metabolic enzymes and sperm abnormalities by fenugreek steroids in testis and epididymis of diabetic rats. Arch Physiol Biochem 2010, 116:146-155.
21. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001, 50:537-546.
22. Grieco F.A., Vendrame F., Spagnuolo I., Dotta F. Innate immunity and the pathogenesis of type 1 diabetes. Semin Immunopathol 2011, 33:57-66.
23. Gupta S., Koirala J., Khardori R., Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am 2007, 21:617-638.
24. Al-Salami H., Butt G., Fawcett J.P., Tucker I.G., Golocorbin-Kon S., Mikov M. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur J Drug Metab Pharmacokinet 2008, 33:101-106.
25. Kingma S.D., Li N., Sun F., Valladares R.B., Neu J., Lorca G.L. Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. JNutr 2011, 141:1023-1028.
26. Lau K., Benitez P., Ardissone A., Wilson T.D., Collins E.L., Lorca G., et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. JImmunol 2011, 186:3538-3546.
27. D'Souza R., Pandeya D.R., Rahman M., Lee H.S., Jung J.K., Hong S.T. Genetic engineering of Lactococcus lactis to produce an amylase inhibitor for development of an anti-diabetes biodrug. New Microbiol 2012, 35:35-42.
28. You Q., Chen F., Wang X., Luo P.G., Jiang Y. Inhibitory effects of muscadine anthocyanins on α-glucosidase and pancreatic lipase activities. JAgr Food Chem 2011, 59:9506-9511.
29. Imagawa, Hanafusa T. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud 2006, 3:169-177.
30. Vergès B. Lipid disorders in type 1 diabetes. Diabetes Metab 2009, 35:353-360.
31. Pigeon R.M., Cuesta E.P., Gilliland S.E. Binding of free bile acids by cells of yogurt starter culture bacteria. JDairy Sci 2002, 85:2705-2710.
32. Liong M.T., Shah N.P. Acid and bile tolerance and the cholesterol removal ability of bifidobacteria strains. Biosci Micro 2005, 24:1-10.
33. Liong M.T., Shah N.P. Roles of probiotics and prebiotics on cholesterol: the hypothesized mechanisms. Nutrafoods 2005, 4:45-57.
34. Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radical Bio Med 2011, 50:567-575.
35. Ozbek E. Induction of oxidative stress in kidney. Int J Nephrol 2012, 2012.
36. Evelson P., Susemihl C., Villarreal I., Llesuy S., Rodríguez R., Peredo H., et al. Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Ann Hepatol 2005, 4:115-120.
37. Arkkila P.E., Koskinen P.J., Kantola I.M., Rönnemaa T., Seppänen E., Viikari J.S. Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes. Diabetes Res Clin Pract 2001, 52:113-118.
38. Farswan M., Mazumder P.M., Percha V. Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats. Indian J Pharmacol 2009, 41:19-22.
39. Mude R.N., Somesula S.R., Adi P.J., Matcha B. Diabetic regulation through blood constituents' modulations on treatment with Aloe Vera in alloxan indiced diabetic rats. Dig J Nanomater Bios 2012, 7:649-655.